Medy-Tox financials at a glance

+ Portfolio

The revenue of Medy-Tox is reported as 220.22925 billion Won in the fiscal year 2023. The earnings were 3831.74 Won per share in 2023, which was 62.28 lower than 2021. And about 34.39667 billion Won are reported as free cash flow in the financials of Medy-Tox 2023. Dividends of 967.73 Won per share were paid to shareholders of Medy-Tox stock KOSDAQ:A086900 in fiscal 2023.

₩195.10B

Revenue

₩5.75k

Earnings Per Share

64.61%

Gross Margin %

₩16.30B

Free Cash Flow

Revenue

195,096.22

Earnings Per Share

5,750.00

Gross Margin %

64.61

Free Cash Flow

16,304.04

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Rev.	Revenue	N/A	₩195.10B	₩184.87B	₩140.83B	₩205.90B	₩205.44B	₩181.24B	₩133.26B	₩88.51B	₩75.89B	₩39.14B	₩36.26B
GM %	Gross Margin %	62.75%	64.61%	57.05%	52.48%	65.98%	73.37%	80.54%	81.66%	83.64%	90.61%	87.05%	90.41%
OM	Operating Margin	15.18%	23.92%	17.93%	-26.32%	12.48%	41.61%	48.00%	56.41%	58.37%	66.15%	42.81%	46.98%
EPS	Earnings Per Share	₩1.40k	₩5.75k	₩15.24k	₩-4,840.82	₩4.17k	₩11.07k	₩11.27k	₩9.06k	₩6.45k	₩6.60k	₩2.14k	₩2.31k
Div.	Dividends	N/A	₩1.83k	₩1.31k	₩907.03	₩691.07	₩754.81	₩1.79k	₩1.63k	₩1.38k	₩1.22k	₩407.12	₩388.85
PR %	Payout Ratio %	0	31.80%	8.60%	-18.74%	16.56%	6.82%	15.90%	17.97%	21.45%	18.50%	18.99%	16.80%
Sha.	Shares	N/AM	6.34M	6.06M	6.11M	6.27M	6.3M	6.48M	6.5M	6.55M	6.56M	6.66M	6.68M
OCF	Operating Cash Flow	N/A	₩26.20B	₩19.97B	₩27.93B	₩33.70B	₩55.07B	₩59.68B	₩54.10B	₩22.36B	₩105.38B	₩16.60B	₩14.78B
FCF	Free Cash Flow	N/A	₩16.30B	₩2.45B	₩-13,216.87M	₩12.68B	₩46.57B	₩21.64B	₩-82,397.77M	₩-7,731.03M	₩88.74B	₩43.08M	₩7.68B
FCFS	Free Cash Flow Per Share	₩-1,413.82	₩167.47	₩-,215.75	₩-2,680.54	₩1.71k	₩7.54k	₩2.27k	₩-15,280.75	₩-1,927.53	₩14.11k	₩-,331.89	₩790.78

Medy-Tox financials at a glance

Financials

Discover